MCLAUGHLIN JOHN PETER 4
4 · PDL BIOPHARMA, INC. · Filed Jan 9, 2019
Insider Transaction Report
Form 4
MCLAUGHLIN JOHN PETER
Director
Transactions
- Disposition to Issuer
Common stock
2018-12-31−123,449→ 502,108 total
Footnotes (1)
- [F1]John McLaughlin retired from the Issuer as of December 31, 2018, and all unvested shares of restricted stock were forfeited back to the Issuer.